Carewise Biotechnology Co., Limited

Carewise Biotechnology Co., Limited (Private company limited by shares) was incorporated on 2026-06-23 under the Companies Ordinance (Cap. 622) of Hong Kong. Pursuant to a special resolution delivered under Section 5 of Cap. 622, the corporation has entered dormant status, holding the legal status of [Dormant] (lawfully exempted from delivering annual returns while maintaining corporate personality) (Statutory records last verified: October 2026).

The sole statutory identifier for Carewise Biotechnology Co., Limited is its 8-digit Business Registration Number (BRN / Unique Business Identifier UBI): [80684143]. Pursuant to Phase 2 of the Unique Business Identifier (UBI) regime implemented by the Hong Kong Companies Registry on 27 December 2023, the 8-digit BRN issued by the Inland Revenue Department serves as the unified statutory identifier across all government departments for newly incorporated companies, and no separate legacy CRN is issued.

Under the Companies Ordinance (Cap. 622), Hong Kong corporations do not have a 'legal representative' role; executive authority vests in the Board of Directors (Section 643). Because Carewise Biotechnology Co., Limited was incorporated within the past year (2026-06-23) and its first Annual Return (Form NAR1) is not yet due, its founding directors, company secretary, and initial share capital allotment are officially recorded in its Incorporation Form (Form NNC1), supplemented by any subsequent Return of Allotment (Form NSC1) or Notice of Change of Director (Form ND2A).

Yes. According to the official statutory records of the Hong Kong Companies Registry, Carewise Biotechnology Co., Limited has officially recorded 1 legal name change(s): [Singlera Genomics International Co., Limited (鵾遠生物國際發展有限公司) (effective 2026-06-23)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Yes. Because Carewise Biotechnology Co., Limited is newly incorporated (under 1 year), pursuant to Section 662 of the Companies Ordinance (Cap. 622), its first Annual Return (Form NAR1) will be due within 42 days after its 1st incorporation anniversary. Official registry records confirm that 8 statutory incorporation dossier(s) are officially archived (latest statutory filing indexed on 2026-10-13: Special Resolution (Dormant Company Status) (Chinese)). The definitive statutory document detailing its founding structure is the Incorporation Form (Form NNC1). Available verified records include barcoded Form NNC1 (revealing founding directors, founder members, issued share capital, and registered office) and Articles of Association (A&A) for immediate online retrieval.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across Hong Kong statutory regulatory registers (including HKMA, SFC, Companies Registry TCSP, Customs MSO/DPMS, and Insurance Authority IA), this entity holds no special statutory financial licence, operating as a general commercial corporation; 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with the Hong Kong Judiciary public writs database and Official Receiver's Office (ORO) registers; no public civil action writs (HCA/DCCJ) or compulsory winding-up petitions (HCCW under Cap. 32) were found on current index records.

The statutory registered office of Carewise Biotechnology Co., Limited on official record is situated at: [ROOM B3, 19/F, TUNG LEE COMMERCIAL BUILDING, 91-97 JERVOIS STREET, SHEUNG WAN, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change. Under Section 3 of the Companies (Disclosure of Company Name and Liability Status) Regulation (Cap. 622B), the company must continuously display its registered name in legible characters at its registered office.

Under Section 127 of the Companies Ordinance (Cap. 622), Hong Kong has abolished the mandatory use of a metallic common seal; Carewise Biotechnology Co., Limited (CRN: Pending registration / 8-digit BRN: 80684143) may lawfully execute a commercial contract without a common seal by having the document signed on its behalf by its sole director (for a single-director company) or by two directors / one director and the company secretary, and under Cap. 622B Section 4 must state its registered legal name on all contracts, transaction instruments, and official websites. Because commercial rubber chops are not registered with the Hong Kong Government, counterparties must retrieve the latest Annual Return (Form NAR1), director change notices (Form ND2A), and Register of Charges filings (Form NM1 under Cap. 622 s.334) from the Companies Registry to verify authorized signatory directors and asset pledges.